Inventor · disambiguated record
Jingrong Cao
Also filed as: BEMIS GUY · CAO JINGRONG
36 granted patents·13 pending applications·1,379 citations·filing 2001–2024
98Inventor score
Top patents by PatentIndex Score
49 records- 0198US6784195B2Pyrazole compositions useful as inhibitors of ERKVERTEX PHARMA·Filed 2001·Granted Aug 31, 2004·182 cites·21 claims
- 0296US8344153B2Inhibitors of phosphatidylinositol 3-kinaseVERTEX PHARMA·Filed 2010·Granted Jan 1, 2013·47 cites·16 claims
- 0396US7084159B2Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinasesVERTEX PHARMA·Filed 2003·Granted Aug 1, 2006·104 cites·12 claims
- 0496US6743791B2Heterocyclic inhibitors of ERK2 and uses thereofVERTEX PHARMA·Filed 2002·Granted Jun 1, 2004·123 cites·57 claims
- 0596US6642227B2Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinasesVERTEX PHARMA·Filed 2002·Granted Nov 4, 2003·109 cites·31 claims
- 0696US6495582B1Isoxazole compositions useful as inhibitors of ERKVERTEX PHARMA·Filed 2001·Granted Dec 17, 2002·104 cites·25 claims
- 0795US7253187B2Heterocyclic inhibitors of ERK2 and uses thereofVERTEX PHARMA·Filed 2004·Granted Aug 7, 2007·90 cites·25 claims
- 0895US6699865B2Pyrazole compositions useful as inhibitors of ERKVERTEX PHARMA·Filed 2003·Granted Mar 2, 2004·71 cites·21 claims
- 0995US6593357B1Pyrazole compositions useful as inhibitors of ERKVERTEX PHARMA·Filed 2002·Granted Jul 15, 2003·81 cites·21 claims
- 1095US6528509B1Pyrazole compositions useful as inhibitors of ERKVERTEX PHARMACUTICALS INC·Filed 2001·Granted Mar 4, 2003·177 cites·21 claims
- 1194US7514448B2Azaindoles useful as inhibitors of rock and other protein kinasesVERTEX PHARMA·Filed 2005·Granted Apr 7, 2009·36 cites·17 claims
- 1293US8466288B2Isoindolinone inhibitors of phosphatidylinositol 3-kinaseARONOV ALEX·Filed 2012·Granted Jun 18, 2013·38 cites·18 claims
- 1393US7056944B2Pyrazole compositions useful as inhibitors of erkVERTEX PHARMA·Filed 2003·Granted Jun 6, 2006·56 cites·24 claims
- 1492US11866446B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2021·Granted Jan 9, 2024·7 cites·55 claims
- 1592US7842686B2CGRP receptor antagonistsVERTEX PHARMA·Filed 2009·Granted Nov 30, 2010·26 cites·23 claims
- 1691US12060346B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2023·Granted Aug 13, 2024·1 cites·53 claims
- 1791US11618746B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2019·Granted Apr 4, 2023·6 cites·28 claims
- 1888US9676759B2Isoindolinone inhibitors of phosphatidylinositol 3-kinaseVERTEX PHARMA·Filed 2013·Granted Jun 13, 2017·8 cites·11 claims
- 1988US8017781B2Azaindazoles useful as inhibitors of kinasesVERTEX PHARMA·Filed 2006·Granted Sep 13, 2011·10 cites·8 claims
- 2088US6649640B2Isoxazole compositions useful as inhibitors of ERKVERTEX PHARMA·Filed 2002·Granted Nov 18, 2003·25 cites·10 claims
- 2186US8445681B2Azaindazoles useful as inhibitors of kinasesBRENCHLEY GUY·Filed 2011·Granted May 21, 2013·10 cites·14 claims
- 2284US8741912B2Deazapurines useful as inhibitors of Janus kinasesLEDEBOER MARK·Filed 2007·Granted Jun 3, 2014·5 cites·6 claims
- 2384US6693108B2Inhibitors of c-JUN N terminal kinases (JNK) and other protein kinasesVERTEX PHARMA·Filed 2002·Granted Feb 17, 2004·20 cites·11 claims
- 2482US12281102B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2021·Granted Apr 22, 2025·1 cites·38 claims
- 2582US12116343B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2021·Granted Oct 15, 2024·1 cites·33 claims
- 2682US7169798B2Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinasesVERTEX PHARMA·Filed 2004·Granted Jan 30, 2007·16 cites·11 claims
- 2779US8163737B2CGRP receptor antagonistsANDERSON COREY·Filed 2007·Granted Apr 24, 2012·6 cites·12 claims
- 2878US8058271B2Selective inhibitors of rock protein kinase and uses thereofGREEN JEREMY·Filed 2007·Granted Nov 15, 2011·3 cites·15 claims
- 2978US2025042878A1Inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 3077US10118904B2Triazoles for the treatment of Demyelinating DiseasesVERTEX PHARMA·Filed 2016·Granted Nov 6, 2018·3 cites·34 claims
- 3176US10183933B2Isoindolinone inhibitors of phosphatidylinositol 3-kinaseVERTEX PHARMA·Filed 2017·Granted Jan 22, 2019·1 cites·10 claims
- 3276US8278306B2C-met protein kinase inhibitorsGREEN JEREMY·Filed 2011·Granted Oct 2, 2012·3 cites·16 claims
- 3375US7354919B2Isoxazole compositions useful as inhibitors of ERKVERTEX PHARMA·Filed 2003·Granted Apr 8, 2008·6 cites·19 claims
- 3473US7834000B2CGRP receptor antagonistsVERTEX PHARMA·Filed 2007·Granted Nov 16, 2010·2 cites·20 claims
- 3571US12421249B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2023·Granted Sep 23, 2025·0 cites·23 claims
- 3671US7612065B2Inhibitors of c-JUN N-terminal kinases (JNK)VERTEX PHARMA·Filed 2007·Granted Nov 3, 2009·1 cites·22 claims
- 3764US2009227607A1Deazapurines useful as inhibitors of janus kinasesLEDEBOER MARK·Filed 2008·Application pending·0 cites
- 3861US2014315931A1Deazapurines useful as inhibitors of janus kinasesVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 3960US2025136612A14',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 4059US2025171459A12-methyl-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 4155US10766869B2Triazoles for the treatment of demyelinating dieasesVERTEX PHARMA·Filed 2018·Granted Sep 8, 2020·0 cites·34 claims
- 4255US2012316186A1Deazapurines useful as inhibitors of janus kinasesLEDEBOER MARK·Filed 2012·Application pending·0 cites
- 4355US2007265263A1Heterocyclic inhibitors of ERK2 and uses thereofCAO JINGRONG·Filed 2007·Application pending·0 cites
- 4453US2023014907A1Inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4552US2012040950A1Isoindolinone inhibitors of phosphatidylinositol 3-kinaseARONOV ALEX·Filed 2010·Application pending·0 cites
- 4645US2013310418A1Azaindazoles useful as inhibitors of kinasesVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 4744US2004122016A1Compositions useful as inhibitors of rock and other protein kinasesFiled 2003·Application pending·0 cites
- 4840US2003096813A1Compositions useful as inhibitors of GSK-3Filed 2002·Application pending·0 cites
- 4936US2003153560A1Inhibitors of c-Jun N-terminal kinases (JNK)Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jingrong Cao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →